Free tool
FAERS Monitor: Foundayo
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 220934 or its brand name (Foundayo, Orforglipron Calcium). Reports on generic versions are filed under their own applications.
Reports
3,056
Serious
138
5% of reports
Hospitalization
58
Death reported
4
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea717
- drug ineffective551
- constipation331
- vomiting282
- weight increased246
- fatigue227
- weight loss poor218
- diarrhoea212
- headache187
- illness147
- abdominal pain upper137
- dizziness130
- dyspepsia115
- abdominal discomfort110
- abdominal distension99
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2025 | 1 |
| 2026 | 3,055 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,103 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| weight loss poorSignal | 218 | 306.5 | 268.8 | 63,270 |
| constipationSignal | 331 | 10.5 | 9.4 | 2,848 |
| illnessSignal | 147 | 9.8 | 8.4 | 1,162 |
| dyspepsiaSignal | 115 | 8.1 | 6.7 | 706 |
| weight increasedSignal | 246 | 7.6 | 6.7 | 1,409 |
| abdominal distensionSignal | 99 | 6.5 | 5.4 | 460 |
| nauseaSignal | 717 | 6.2 | 5.9 | 3,270 |
| abdominal pain upperSignal | 137 | 4.6 | 3.9 | 384 |
| abdominal discomfortSignal | 110 | 4.5 | 3.8 | 300 |
| vomitingSignal | 282 | 4.1 | 3.7 | 681 |
| drug ineffectiveSignal | 551 | 2.9 | 2.7 | 718 |
| diarrhoeaSignal | 212 | 2.3 | 2.0 | 152 |
| headacheSignal | 187 | 2.1 | 1.8 | 103 |
| fatigueSignal | 227 | 2.0 | 1.8 | 118 |
| dizziness | 130 | 1.8 | 1.5 | 46 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.